Showing 1751-1760 of 3223 results for "".
- Eli Lilly Enters Ophthalmology Sector with Acquisition of Adverum Biotechnologieshttps://modernod.com/news/eli-lilly-enters-ophthalmology-sector-with-acquisition-of-adverum-biotechnologies/2484212/Eli Lilly and Company and Adverum Biotechnologies announced that they have entered into a definitive agreement for Lilly to acquire Adverum Biotechnologies, including its lead gene therapy product candidate, Ixo-vec. I
- Iantrek Announces US Commercial Launch of AlloFlo Uveo, First Surgical Treatment Targeting the Uveoscleral Pathwayhttps://modernod.com/news/iantrek-announces-us-commercial-launch-of-alloflo-uveo-first-surgical-treatment-targeting-the-uveoscleral-pathway/2484180/Iantrek announced the official US commercial launch of AlloFlo Uveo, the first surgical treatment specifically designed to target the uveoscleral pathway. This milestone follows Iantrek’s $42 million Se
- Alcon Showcases Breakthrough Innovations and New Clinical Data at AAO 2025https://modernod.com/news/alcon-showcases-breakthrough-innovations-and-new-clinical-data-at-aao-2025/2484167/Alcon will highlight a lineup of new technologies and clinical data at the 2025 American Academy of Ophthalmology (AAO) annual meeting, October 18–20, in Orlando. At booth #2120, ophthalmologists, surgical staff,
- FDA Grants Fast Track Designation to Aldeyra’s ADX-2191 for Retinitis Pigmentosahttps://modernod.com/news/fda-grants-fast-track-designation-to-aldeyras-adx-2191-for-retinitis-pigmentosa/2484124/The FDA has granted Fast Track Designation for Aldeyra Therapeutics' ADX-2191 (methotrexate intravitreal injection, USP) for the treatment of retinitis pigmentosa (RP). The FDA’s Fast Track progra
- Alcon to Acquire Staar Surgical for $1.5 Billionhttps://modernod.com/news/alcon-to-acquire-staar-surgical-for-15-billion/2482917/In a major deal to expand its refractive portfolio and continue its spree of acquisitions, Alcon has agreed to acquire Staar Surgical, maker of the Implantable Collamer Lens (ICL). The acquisition includes the EVO family of l
- Alcon Announces US Launch of Tryptyr for Dry Eye Diseasehttps://modernod.com/news/alcon-announces-us-launch-of-tryptyr-for-dry-eye-disease/2482908/Alcon announced the US commercial availability of Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease (DED). Approved by the FDA in May, eye care professionals (ECPs) across the US can officially begin p
- Alcon Showcases Surgical Efficiency of Unity VCS Innovations at ASRS 2025https://modernod.com/news/alcon-showcases-surgical-efficiency-of-unity-vcs-innovations-at-asrs-2025/2482903/Alcon will showcase its latest clinical data and innovations at the 2025 American Society of Retina Specialists (ASRS) annual meeting, July 31 to August 2, in Long Beach, California. Attendees can explore Alcon’s latest surgical advancements through scientific presentations and hands-on dem
- Opus Genetics and the Global RDH12 Alliance Partner to Advance RDH12 Gene Therapy for Inherited Childhood Blindnesshttps://modernod.com/news/opus-genetics-and-the-global-rdh12-alliance-partner-to-advance-rdh12-gene-therapy-for-inherited-childhood-blindness/2482902/Opus Genetics announced a partnership with the Global RDH12 Alliance to advance Opus’ gene therapy program for patients with vision loss due to retinol dehydrogenase 12 (RDH12) gene mutations. The Alliance serves as a collaborative platform uniting advocacy groups dedicated to RDH
- Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space Delivery Platformhttps://modernod.com/news/clearside-biomedical-announces-plan-to-explore-strategic-alternatives-to-advance-its-proprietary-suprachoroidal-space-delivery-platform/2482892/Clearside Biomedical announced it has initiated a formal process to explore a range of strategic alternatives aimed at maximizing shareholder value and advancing its pipeline. To support this initiative, Clearside has
- Altris AI Launches Altris Sync App Allowing AI to Directly Sync to OCT Deviceshttps://modernod.com/news/altris-ai-launches-altris-sync-app-allowing-ai-to-directly-sync-to-oct-devices-ai-now-connects-to-oct-devices-from-8-manufacturers-and-enables-analysis-of-historical-data/2482891/Altris AI announces the release of 'Altris Sync,' a secure application that syncs AI directly to OCT devices from 8 OCT manufacturers. The introduction of Altris Sync for automated upload of OCT files is desinged to remove the need for manual operations and bring AI de